Truace
Subscribe

Therapeutic chatbots in psychiatric care

Source article: [Therapeutic chatbots in psychiatry: Between relational simulation and the reshaping of care]

Introduction: The rapid development of conversational agents, or chatbots, in mental health is part of a broader transformation of digital psychiatry. Alongside advances in artificial intelligence, digital phenotyping, and ecological momentary interventions, therapeutic chatbots challenge not only the practical organisation of care but also its epistemological and relational foundations. This article aims to critically examine their place in psychiatry, particularly with regard to therapeutic alliance, agency, a…

By the Truvace desk1 min read1 sourcePeer-reviewedTRV-2026-2208· cite & verify
[Therapeutic chatbots in psychiatry: Between relational simulation and the reshaping of care]
Maintaining Resilience Through Mental Health (9178156) by U.S. Air Force photo by Staff Sgt. Sean Moriarty. Public domain
Trace impact readingNegative state
P 73The P score combines the specificity and measured human impact of the grounded problem claim with the strength of this Trace’s cited sources.

Both sides are scored from claims and sources, not community votes.

G 68The G score combines the specificity and measured human impact of the grounded gain claim with the strength of this Trace’s cited sources.

In brief

A conceptual and narrative review examined how conversational agents are used in mental health care. It looked at their types, clinical uses, evidence on efficacy and acceptability, and the ethical and theoretical questions raised by bringing them into psychiatry.

The review matters because it argues chatbots should be judged by functions such as self-monitoring and attention modulation rather than by how well they imitate a human therapist. Their durable benefit, safety and governance remain unsettled, so supervised, validated use is emphasised.

Main points

  1. The review is conceptual and narrative rather than a new trial, and it covers chatbot typology, clinical uses, efficacy, acceptability and ethics.
  2. Available studies suggest modest short-term improvement in depressive and anxiety symptoms.
  3. Effects look less consistent over the medium term.
  4. Possible clinical value lies in self-monitoring, attention modulation, reinforcing adaptive behaviours and contextualised interventions.
  5. Chatbots are framed as hybrid components of distributed care, not clinician substitutes.

The gain

Chatbots may produce modest short-term improvements in depressive and anxiety symptoms and boost engagement with digital interventions.

The problem

Chatbot effects appear less consistent over the medium term, and concerns remain about data confidentiality, reliability, clinical integration and human oversight.

The rundown

The authors place therapeutic chatbots within a wider shift in digital psychiatry that also includes digital phenotyping and ecological momentary interventions. They say chatbots challenge both the organisation of care and its epistemological and relational foundations.

They focus on therapeutic alliance, agency and patient autonomy, and use concepts such as relational simulation, distributed agency and attentional modulation to assess how chatbots fit into care.

Their conclusion calls for robust clinical validation, transparent governance, respect for patient autonomy and continued human supervision when chatbots are integrated into care systems.

What this doesn’t fix

The evidence is drawn from a narrative review, and the authors report that medium-term effects are less consistent and that confidentiality, reliability, integration and oversight concerns remain unresolved.

Sources

  1. Peer-reviewedL'Encéphale2026-10-21

The debate